News Stories

Should cannabis still be a Schedule I drug?

Oct. 9, 2023

The Drug Enforcement Agency received a recommendation to reclassify cannabis as a Schedule III drug, a move that would be a boon to research and patient care.

Comprehensive Center for Pain and Addiction researchers say reclassifying cannabis as a Schedule III substance would loosen the restraints on research into possible benefits, as well as any potential negative side effects, of medical marijuana.

Paving a path for Valley fever research, treatment, prevention

Oct. 2, 2023

For four decades, John Galgiani, MD, has pioneered translational research and clinical care for Valley fever, a disease more common in Arizona than anywhere else.

Insights: Vaccines, variants and COVID-19 trends

Sept. 26, 2023

Immunologist Deepta Bhattacharya discusses the newest COVID-19 vaccines and what the future might hold for COVID-19 immunizations.

A recent upswing in COVID-19 cases in the U.S. increased conversations about the newest COVID-19 vaccine, which targets the XBB variant.

Researchers hope to help women with endometriosis pain

Sept. 19, 2023

Comprehensive Pain and Addiction Center researchers are examining the link between prolactin and endometriosis, a painful condition that affects women.

Researchers are examining the role of a hormone called prolactin in the pain of endometriosis and how endometriosis might predispose women to other pain conditions.

On a personal journey to solve the migraine puzzle

Sept. 12, 2023

Tally Largent-Milnes, PhD, who once aspired to be a physician, has carved out an impactful space in the field of migraine research.

Competitive and curious from a young age, Tally Largent-Milnes, PhD, is driven to understand what triggers migraine headaches and how researchers can develop more effective therapies for people, including herself, who live with the neurological disease.

Casting a green light on fibromyalgia, the invisible disease

Sept. 7, 2023

People with fibromyalgia may have another treatment option available soon thanks to continuing research at the Comprehensive Pain and Addiction Center.

Researchers at the University of Arizona Health Sciences are exploring green light therapy as a potential treatment option for people with fibromyalgia, a puzzling disease that affects approximately 10 million people — mostly women — in the U.S.

Dynamic training prepares physician for career in research

Aug. 31, 2023

A surgeon is learning how to use data science skills to boost research and turn discoveries into practical treatments for patients.

Chidiebere “Peter” Echieh, MD, FWACS, is enhancing his research capabilities with skills acquired in the Data Science Fellows program while also learning how to turn discoveries in the lab into practical solutions in the Clinical Translational Sciences program.

An innovative approach to increase health literacy

Aug. 15, 2023

The K-12 Health Literacy Project is introducing the importance of science and health to local students while training future providers to communicate effectively.

University of Arizona student interns in the Health Connectors program presented science and health information to elementary school children as part of a UArizona Health Sciences initiative to increase health literacy.

On a mission to lead the next class of physician assistants

Aug. 8, 2023

Kevin Lohenry’s military experience guided him toward a career as a physician assistant and is helping him prepare the next generation of health care providers.

After serving in the Navy, Kevin Lohenry, PhD, PA-C, embarked on a career as a physician assistant and now is leading others to the profession as interim dean of the University of Arizona College of Health Sciences.

Using data to make better medical decisions

Aug. 3, 2023

The Data Science Fellowship equips health care researchers and professionals to leverage data to improve medical knowledge and care.